EHMTI-0108. Efficacy of therapy in patients with migraine: comparison in group of < 9 migraines and > 10 migraines per month by unknown
MEETING ABSTRACT Open Access
EHMTI-0108. Efficacy of therapy in patients with
migraine: comparison in group of < 9 migraines
and > 10 migraines per month
V Vukovic Cvetkovic1*, S Zupanic2, M Bosnar Puretic3
From 4th European Headache and Migraine Trust International Congress: EHMTIC 2014
Copenhagen, Denmark. 18-21 September 2014
Aims
To investigate the efficacy of acute and prophylactic
migraine therapy in groups of patients with < 9 migraines
and > 10 migraines per month (p.m.).
Methods
All consecutive patients with migraine that attended one
single tertiary outpatient care service during 2011. were
analysed. Migraine was diagnosed according to the
ICHD II criteria.
Results
A total of 380 patients were analysed; 262 (68.9%) patients
with < 9 migraines pm (222 women, 40 men) (group A),
39 (10.3%) patients with 10-14 migraines p.m. (30 women,
9 men) (group B) and 79 (20.8%) patients with > 15
migraines p.m. (66 women, 13 men) (group C). In group
A 72.1% declared that triptans were efficient, 8.1% partly
and 12.6 not efficient; in group B 82.8% declared that trip-
tans were efficient and 18.2 partly efficient; in group C
44.4% declared that triptans were very efficient, 22.2%
partly and 33.3% not efficient. Adverse events were present
in 9%, 9.1% and 11.1% respectively. In group A 102
(38.9%) was on prophylaxis, 47.1% declared efficacy > 50%,
18.6% declared efficacy 25-50% and 21.6% declared efficacy
less than 25%. In group B 14 (35.9)% was on prophylaxis,
14.3% declared efficacy > 50%, 7.1% declared efficacy 25-
50% and 57.1% declared efficacy less than 25%. In group C
24 (30.4%) was on prophylaxis, 4.2% declared efficacy >
50%, and 79.2% declared efficacy less than 25%. Adverse
events were present in 9.3%, 21.4% and 16.7% respectively.
Conclusions
Migraine patients with less frequent attacks respond
better to acute and prophylactic therapy. More attention
should be given to patients with frequent attacks in
order to provide them more efficient therapy.
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